Scientific Sessions 2024  /  Meet the Trialists: nex-Z and BPROAD  /  Meet the Trialist: BPROAD: Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes
Logo

American Heart Association

  2
  0

Final ID:

Meet the Trialist: BPROAD: Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes

  • Ning, Guang  ( Guang-Shanghai Jiao Tong University , Shanghai , China )
    • Author Disclosures:
    Guang Ning: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Meet the Trialists: nex-Z and BPROAD

Saturday, 11/16/2024 , 03:15PM - 04:00PM

Meet the Trialist

More abstracts on this topic:
Meet the Trialist: Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study

Fontana Marianna

More abstracts from these authors:
Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes

Ning Guang, Wang Weiqing, He Jiang, Bi Yufang, Xu Yu, Li Mian

You have to be authorized to contact abstract author. Please, Login
Not Available